AWK vs LYEL · P/E 22, rev $4.65B vs rev $61.0K
American Water Works (AWK) versus Lyell Immunopharma Inc (LYEL) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported LYEL revenue for 2024-12-31 was $61.0K. Net income was -$343.0M. Revenue was down 53.1% from 2023-12-31 to 2024-12-31. LYEL currently screens at market cap $143.5M.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. LYEL currently screens at market cap $143.5M.
Not investment advice. Open the AWK and LYEL stock pages for the full models.
Not investment advice.